MERCK Kommanditgesellschaft auf Aktien

(PINK:MKKGY)

Latest On MERCK Kommanditgesellschaft auf Aktien (MKKGY):

Date/Time Type Description Signal Details
2024-04-29 05:57 ESTDividendA dividend of $0.47 has been announced on Apr 4, 2024. It will be paid May 9, 2024 with an ex-dividend date of Apr 29, 2024.Neutral
2023-05-12 03:03 ESTNewsMerck KGaA (MKGAF) Q1 2023 Earnings Call TranscriptN/A
2023-05-11 12:59 ESTNewsMerck KGaA 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-02 05:56 ESTDividendA dividend of $0.47 has been announced on Mar 16, 2023. It will be paid May 11, 2023 with an ex-dividend date of May 2, 2023.Neutral
2023-04-29 01:55 ESTNewsGermany rebuffs report it is pursuing chemical export control to ChinaN/A
2023-04-27 12:25 ESTNewsGermany may limit exporting of chemicals used for semiconductors to ChinaN/A
2023-04-18 17:20 ESTNewsMerck KGaA: A German Free Cash Flow MachineN/A
2023-04-12 10:16 ESTNewsMerck KGaA stock falls after FDA pauses new patients on MS drug evobrutinib in trialN/A
2023-03-27 23:18 ESTNewsPfizer and Merck KGaA end global collaboration for cancer therapy BavencioN/A
2023-03-03 00:20 ESTNewsMERCK Kommanditgesellschaft auf Aktien (MKGAF) Q4 2022 Results - Earnings Call TranscriptN/A
2023-03-03 00:20 ESTNewsMERCK Kommanditgesellschaft auf Aktien 2022 Q4 - Results - Earnings Call PresentationN/A
2023-01-04 12:37 ESTNewsTrim Big Pharma For Merck KgaAN/A
2022-12-23 16:48 ESTNewsMersana Therapeutics in deal with Merck KGaA for antibody-drug conjugatesN/A
2022-12-23 00:14 ESTNewsMersana Therapeutics in deal with Merck KGaA for antibody drug conjugatesN/A
2022-11-29 16:05 ESTNewsPfizer, Merck KGaA join Immutep in Phase 1 trial for kidney cancer therapyN/A
2022-11-16 20:51 ESTNewsMerck KGaA to invest $286M at Maryland site to boost drug safety testing capacityN/A
2022-11-11 02:10 ESTNewsMERCK Kommanditgesellschaft auf Aktien (MKGAF) CEO Belen Garijo on Q3 2022 Results - Earnings Call TranscriptN/A
2022-11-10 08:34 ESTNewsMerck KGaA Q3 sales grow on back of Life Science business, confirms FY22 outlookN/A
2022-10-26 08:54 ESTNewsMerck KGaA multiple sclerosis drug evobrutinib shows benefit across 3 years in trialN/A
2022-10-19 17:28 ESTNewsMerck KGaA to be probed in France over thyroid drug levothyroxN/A
2022-10-11 22:50 ESTNewsPDS Biotech stock soars 14% as PDS0101 shows promise vs HPV-positive cancers in interim trial dataN/A
2022-10-07 08:58 ESTNewsMerck KGaA mulls 'larger-scale acquisitions' from 2023 onwards; focus on 'Big 3' for sales growthN/A
2022-09-21 17:32 ESTNewsMerck KGaA in licensing deal with Nerviano Medical for PARP inhibitorN/A
2022-09-08 20:33 ESTNewsMilliporeSigma, subsidiary of Merck KGaA to invest €130M for strengthening manufacturing capabilities in FranceN/A
2022-08-31 21:55 ESTNewsGuardant Health expands collaboration with Merck KGaA on precision oncology therapiesN/A
2022-08-09 13:04 ESTNewsMERCK Kommanditgesellschaft auf Aktien (MKGAF) CEO Belen Garijo on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-04 19:41 ESTNewsMerck KGaA Q2 sales grow on all-round show, raises FY22 outlookN/A
2022-08-04 19:41 ESTNewsMERCK Kommanditgesellschaft auf Aktien 2022 Q2 - Results - Earnings Call PresentationN/A
2022-06-01 23:43 ESTNewsMerck KGaA, South Korea's Standigm team up for AI-based drug discovery researchN/A
2022-05-23 07:31 ESTNewsMerck KGaA to invest ~€440M to boost manufacturing capacity in IrelandN/A
2022-05-14 06:25 ESTNewsMerck KGaA (MKGAF) CEO Belén Garijo on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-13 03:31 ESTNewsMERCK Kommanditgesellschaft auf Aktien Non-GAAP EPS of €2.41, revenue of €5.2B; updates FY22 guidanceN/A
2022-05-13 03:31 ESTNewsMERCK Kommanditgesellschaft auf Aktien 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-12 07:32 ESTNewsMerck KGaA Q1 sales rises on the back of Life Science business; confirms FY22 outlookN/A
2022-04-25 05:56 ESTDividendA dividend of $0.41 has been announced on Mar 17, 2022. It will be paid May 4, 2022 with an ex-dividend date of Apr 25, 2022.Neutral
2022-04-08 07:44 ESTNewsPfizer-Merck KGaA's Bavencio gets UK's NICE backing for use in bladder cancerN/A
2022-03-08 05:06 ESTNewsMerck KGaA weighs sale of pigments business valued at over 1 billion dollarsN/A
2022-03-03 20:59 ESTNewsMERCK Kommanditgesellschaft auf Aktien 2021 Q4 - Results - Earnings Call PresentationN/A
2022-03-03 20:59 ESTNewsMERCK Kommanditgesellschaft auf Aktien (MKGAF) CEO Belén Garijo on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-19 03:13 ESTNewsMerck KGaA Bavencio shows survival benefit in bladder cancer in long term dataN/A
2022-02-08 09:08 ESTNewsMerck KGaA integrates CDMO, Contract Testing in new Life Science Services organizationN/A
2021-12-30 21:38 ESTNewsGerman Merck unit awarded ~$137M DoD contract for material used in rapid COVID testsN/A
2021-12-30 04:37 ESTNewsMilliporeSigma wins $136.7M U.S. government contractN/A
2021-12-07 21:33 ESTNewsPalantir, Merck partner to tackle chip shortageN/A
2021-11-24 09:21 ESTNewsMerck KGaA partner granted FDA Fast Teck Designation for cancer drugN/A
2021-11-11 16:45 ESTNewsMERCK Kommanditgesellschaft auf Aktien (MKGAF) CEO Belén Garijo on Q3 2021 Results - Earnings Call TranscriptN/A
2021-10-01 02:47 ESTNewsGlaxoSmithKline, Merck KGaA end partnership for cancer therapyN/A
2021-09-09 15:36 ESTNewsMerck KGaA to leverage “Big 3” in pursuit of €25 billion group revenue in 2025N/A
2021-08-23 18:52 ESTNewsMerck KGaA halts mid-stage trial for bintrafusp alfa in biliary tract cancerN/A
2021-08-08 04:09 ESTNewsMERCK Kommanditgesellschaft auf Aktien (MKGAF) CEO Belen Garijo on Q2 2021 Results - Earnings Call TranscriptN/A

About MERCK Kommanditgesellschaft auf Aktien (MKKGY):

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It offers prescription medicines to treat cancer or multiple sclerosis, infertility, growth hormone deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, as well as carcinoma of the head and neck; prescription drugs for allergen immunotherapy; and fertility treatments. The company also provides life science products and services for the research and applied laboratory applications, as well as for formulating, purifying, manufacturing, and quality-assuring drug therapies of chemical and biological origin; and specialty chemicals, such as liquid crystals and OLED materials for use in displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions. It has strategic alliances with Pfizer Inc. and GlaxoSmithKline plc; agreement with Intrexon Corporation and Avillion LLP; collaboration with F-star Delta Ltd.; an agreement IAVI and Serum Institute of India Pvt. Ltd. to develop SARS-CoV-2 neutralizing monoclonal antibodies; and collaboration with Iktos for new drug design. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.

See Advanced Chart

General

  • Name MERCK Kommanditgesellschaft auf Aktien
  • Symbol MKKGY
  • Type Common Stock
  • Exchange PINK
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 58,127
  • Last Split Factor1666:1000
  • Last Split Date2017-08-15
  • Fiscal Year EndDecember
  • Web URLhttp://www.merckgroup.com
View More

Valuation

  • Trailing PE 31.86
  • Forward PE 19.19
  • Price/Sales (Trailing 12 Mt.) 3.35
  • Price/Book (Most Recent Quarter) 3.46
  • Enterprise Value Revenue 4.71
  • Enterprise Value EBITDA 16.67
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Profit Margin 11%
  • Return on Assets 5%
  • Return on Equity 11%
  • Earnings Per Share $1.04
  • Revenue Per Share $0
  • Gross Profit 10.75 billion
  • Quarterly Earnings Growth 5%
View More

Highlights

  • Market Capitalization 71.43 billion
  • PEG Ratio 3.08
  • Analyst Target Price $28
  • Book Value Per Share $8.17
View More

Share Statistics

  • Shares Outstanding 2.17 billion
  • Shares Float 646.2 million
  • % Held by Insiders <1%
  • % Held by Institutions 0.18%
View More

Technicals

  • Beta 0.44
  • 52 Week High $36.5
  • 52 Week Low $17.25
  • 50 Day Moving Average 33.07
  • 200 Day Moving Average 31.92
View More

Dividends

  • Forward Annual Dividend Rate $0.29
  • Forward Annual Dividend Yield 0.91%
  • Payout Ratio 6%
  • Dividend Date 2020-06-10
  • ExDividend Date 2020-06-01
  • Dividend Per Share $1.46
  • Dividend Yield 0%
View More

MERCK Kommanditgesellschaft auf Aktien (MKKGY) Dividend Calendar:

MKKGY's last dividend payment was made to shareholders on June 10, 2020.
MERCK Kommanditgesellschaft auf Aktien pays out 6% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

MERCK Kommanditgesellschaft auf Aktien (MKKGY) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-04$N/A$0.24
2020-09-302020-12-31$N/A$1.22
2020-06-302020-09-30$N/A$2.17
2020-03-312020-06-30$4.37 billion$0.75
2019-12-312020-03-31$4.91 billion$1.16
2019-09-302019-12-31$4.42 billion$0.86
2019-06-302019-09-30$4.51 billion$0.86
2019-03-312019-06-30$4.2 billion$1.10
2018-12-312019-03-31$4.46 billion$0.51
2018-09-302018-12-31$4.34 billion$0.47
2018-06-302018-09-30$4.32 billion$0.85
2018-03-312018-06-30$4.29 billion$0.65
2017-12-312018-03-31$4.62 billion$0.94
2017-09-302017-12-31$4.37 billion$2.84
2017-06-302017-09-30$4.45 billion$1.67
2017-03-312017-06-30$3.86 billion$1.08
2016-12-312017-03-31$3.83 billion$1.20
2016-09-302016-12-31$0.65
2016-06-302016-09-30$1.18
2016-03-312016-06-30$0.80
2015-12-312016-03-31$1.55
2015-09-302015-11-12$0.19
2015-06-302015-09-30$0.94
2015-03-312015-06-30$0.88
2014-12-312015-03-31$0.70
2014-09-302014-12-31$0.78
2014-06-302014-09-30$0.72
2014-03-312014-06-30$0.96
2013-12-312014-03-31$1.03
2013-09-302013-12-31$0.89
2013-06-302013-09-30$1.06
2013-03-312013-06-30$0.95
2012-12-312013-03-31$0.78
2012-09-302012-12-31$0.82
2012-06-302012-09-30$0.55
2012-03-312012-06-30-$0.18
2011-12-312012-03-31$0.53
2011-09-302011-12-31$0.40
2011-06-302011-09-30$0.69
2011-03-312011-06-30-$0.30
2010-12-312011-03-31$1.10
2010-09-302010-12-31$0.14
2010-06-302010-07-29$0.11
2010-03-312010-04-28$0.12
2009-12-312010-02-23$0.04
2009-09-302009-10-26$0.10
2009-06-302009-07-24$0.07
2009-03-312009-04-27$0.03
2008-12-312009-02-18-$0.17
2008-09-302008-10-27$0.14
2008-06-302008-07-23$0.15
2008-03-312008-04-23$0.17

MERCK Kommanditgesellschaft auf Aktien (MKKGY) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

MERCK Kommanditgesellschaft auf Aktien (MKKGY) Chart:

MERCK Kommanditgesellschaft auf Aktien (MKKGY) News:

Below you will find a list of latest news for MERCK Kommanditgesellschaft auf Aktien (MKKGY) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

MERCK Kommanditgesellschaft auf Aktien (MKKGY) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

MERCK Kommanditgesellschaft auf Aktien (MKKGY) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link